32 Biosciences
32 Biosciences45
About
What does 32 Biosciences do?
32 Biosciences pioneers gut mucosal-immune science to prevent and treat gastrointestinal diseases. Their GI Discovery Platform measures metabolomic signatures to enable therapeutic discovery, and their CS Therapeutic Platform develops Mucosal Immune Modulator (MIM) therapeutics that restore and protect the gastrointestinal mucosal-immune barrier. They focus on preventing and treating GI diseases with novel therapeutics.
What is 32 Biosciences's revenue?
StartupHub estimates 32 Biosciences's annual revenue at $1.9M (range $1.1M to $4.5M, 65% confidence), based on comparable companies in the sector.
What is 32 Biosciences's valuation?
StartupHub estimates 32 Biosciences's effective valuation at $44.9M (range $30.0M to $72.0M, 18% confidence), based on comparable companies in the sector.
How much funding has 32 Biosciences raised?
32 Biosciences has raised a total of $12M in funding.
Where is 32 Biosciences headquartered?
32 Biosciences is headquartered in San Diego, United States.
When was 32 Biosciences founded?
32 Biosciences was founded in 2017.
What industry does 32 Biosciences operate in?
32 Biosciences operates in Biotech, Drug Discovery, Oncology, Autoimmune Diseases, Therapeutic Antibodies, Clinical Trials.
How many employees does 32 Biosciences have?
32 Biosciences has approximately 9 people on record.
No comments yet. Be the first to share your take.